These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23420083)

  • 1. HAS to be NICE?
    de Pouvourville G
    Eur J Health Econ; 2013 Jun; 14(3):363-6. PubMed ID: 23420083
    [No Abstract]   [Full Text] [Related]  

  • 2. Economic evaluation and pharmaceutical reimbursement reform in South Korea's National Health Insurance.
    Yang BM; Bae EY; Kim J
    Health Aff (Millwood); 2008; 27(1):179-87. PubMed ID: 18180493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare program; schedule of limits on hospital inpatient general routine operating costs for cost reporting periods beginning on or after July 1, 1979: correction.
    Fed Regist; 1979 Jul; 44(142):43109. PubMed ID: 10324760
    [No Abstract]   [Full Text] [Related]  

  • 4. Appellate court allows reimbursement for amortized land use costs.
    Gerst RJ; Windisch MS
    Health Law Vigil; 1983 Dec; 6(25):2-3. PubMed ID: 10263854
    [No Abstract]   [Full Text] [Related]  

  • 5. How to prepare and present an appeal to the PRRB.
    Memel SL; Tichon MJ
    Top Health Care Financ; 1979; 5(3):63-73. PubMed ID: 371076
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost containment act has serious flaws.
    Marron J
    Hospitals; 1979 Jun; 53(11):68, 72, 77. PubMed ID: 428952
    [No Abstract]   [Full Text] [Related]  

  • 7. [Price of medications: the actual system must be seen again].
    Mayencourt J
    Rev Med Suisse; 2016 Mar; 12(508):479. PubMed ID: 27089613
    [No Abstract]   [Full Text] [Related]  

  • 8. Third party reimbursement for participation in cancer clinical trials: a proposal for legislation.
    Plaue GM
    J Contemp Health Law Policy; 2000; 16(2):305-54. PubMed ID: 10921232
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug prescriptions outside the marketing product license and its responsibilities].
    Gromb S; Maurain C; Carbonnel S
    Presse Med; 2000 May 27-Jun 3; 29(19):1053-7. PubMed ID: 10874916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pennsylvania cap on Medicaid begins after governor's veto of legislature's opposition.
    Hospitals; 1978 Aug; 52(16):19. PubMed ID: 352900
    [No Abstract]   [Full Text] [Related]  

  • 11. Reimbursement for unlabeled medication use.
    Brushwood DB
    Am J Health Syst Pharm; 1999 Feb; 56(3):257-9. PubMed ID: 10030514
    [No Abstract]   [Full Text] [Related]  

  • 12. Economic aspects of the new Spanish laws on pharmaceutical preparations.
    Antoñanzas F; Oliva J; Pinillos M; Juàrez C
    Eur J Health Econ; 2007 Sep; 8(3):297-300. PubMed ID: 17401592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Australian guidelines for cost-effectiveness studies of pharmaceuticals: the thin end of the boomerang?
    Drummond M
    Pharmacoeconomics; 1992; 1(Suppl 1):61-9. PubMed ID: 10146934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real medical benefit assessed by indirect comparison.
    Falissard B; Zylberman M; Cucherat M; Izard V; Meyer F
    Therapie; 2009; 64(3):225-32. PubMed ID: 19671436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Court to consider Medicare reimbursement for cost of compliance with CON condition.
    Green MJ
    Health Law Vigil; 1980 May; 3(10):5-6. PubMed ID: 10297911
    [No Abstract]   [Full Text] [Related]  

  • 16. The Provider Reimbursement Review Board.
    Cleverley WO
    Top Health Care Financ; 1979; 5(3):vi-vii. PubMed ID: 371071
    [No Abstract]   [Full Text] [Related]  

  • 17. Courts refusing to overrule agencies.
    Horty JF
    Mod Healthc; 1979 Aug; 9(8):92. PubMed ID: 460126
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicare and Medicaid programs; schedule of limits on skilled nursing facility inpatient routine service costs--Health Care Financing Administration. Final notice.
    Fed Regist; 1981 Sep; 46(189):48026-31. PubMed ID: 10298302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keeping an eye on the medical technology store.
    Stein J
    Natl J (Wash); 1979 Jun; 11(23):958, 960-1. PubMed ID: 10297459
    [No Abstract]   [Full Text] [Related]  

  • 20. Proliferating regs will tighten reimbursement.
    Simler SL
    Mod Healthc; 1980 Feb; 10(2):52. PubMed ID: 10297709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.